+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Months +
All Genders
ID05476939

Comparing ONC201 and Everolimus for Treatment of Diffuse Intrinsic Pontine Glioma and Related Diffuse Midline Gliomas

Led by Gustave Roussy, Cancer Campus, Grand Paris · Updated on 2026-10-21

433

Participants Needed

56

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the BIOMEDE 2.0 study, a phase 3 clinical trial to evaluate and compare the effectiveness of ONC201 versus everolimus in treating patients with Diffuse Intrinsic Pontine Glioma DIPG and related diffuse midline gliomas. This multicenter randomized trial aims to determine if ONC201 is superior to everolimus in improving progression-free survival. Patients with these brain tumors will be enrolled, and the study may also compare results to historical controls. Participants will be randomly assigned to receive either everolimus tablets once daily or ONC201 capsules twice weekly according to specified dosing schedules. All patients will also undergo radiotherapy as part of standard care. Treatment continues until unacceptable toxicity, confirmed tumor progression, or withdrawal of consent. After disease progression, patients may switch to the other treatment arm following a 7-day washout period or receive reirradiation if applicable. Throughout the study, participants will undergo regular clinical and radiological evaluations to monitor tumor status and side effects. The primary outcome measured is progression-free survival up to two years after the last patient is included. Secondary outcomes include overall survival, safety profiles, and complication rates related to diagnostic biopsies, with long-term follow-up extending up to five years. Patients will be closely monitored for treatment tolerability and disease progression during the trial period.

CONDITIONS

Brief Title

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Research Team

J

Jacques GRILL, MD, PhD

A

Anne-Sophie BLANC, PharmD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here